NanoString Launches nCounter Stem Cell Characterization Panel To ‘Advance the Development of Stem Cell Therapy’
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the